156 related articles for article (PubMed ID: 29789192)
21. [Submacular hemorrhage with retinal detachment due to an overdose of anticoagulant during age-related macular degeneration].
Grondin C; Pascal ML; Bourdon H; Vu Q; Beaujeux P; Koch E
J Fr Ophtalmol; 2019 Feb; 42(2):215-218. PubMed ID: 30679121
[No Abstract] [Full Text] [Related]
22. [Anticoagulant therapy complicated by ureteric haematoma: A case report].
Cabaniols L; Laffargue G; Gres P; Guiter J; Thuret R
Prog Urol; 2008 Sep; 18(8):550-2. PubMed ID: 18760747
[TBL] [Abstract][Full Text] [Related]
23. Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa).
Daveluy A; Géniaux H; Thibaud L; Mallaret M; Miremont-Salamé G; Haramburu F
Therapie; 2014; 69(6):519-20. PubMed ID: 25230280
[TBL] [Abstract][Full Text] [Related]
24. Effect of body weight on efficacy and safety of direct oral anticoagulants in the treatment of patients with acute venous thromboembolism: a meta-analysis of randomized controlled trials.
Di Minno MN; Lupoli R; Di Minno A; Ambrosino P; Scalera A; Dentali F
Ann Med; 2015 Feb; 47(1):61-8. PubMed ID: 25665582
[TBL] [Abstract][Full Text] [Related]
25. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
[TBL] [Abstract][Full Text] [Related]
26. [Therapy education for patients receiving oral anti-coagulants vitamin K antagonists].
Satger B; Blaise S; Fontaine M; Yver J; Allenet B; Baudrant M; Pernod G; Bosson JL
Presse Med; 2009 Dec; 38(12):1780-7. PubMed ID: 19815369
[TBL] [Abstract][Full Text] [Related]
27. Risk factors of vitamin K antagonist overcoagulation. A case-control study in unselected patients referred to an emergency department.
Cadiou G; Varin R; Levesque H; Grassi V; Benichou J; Tiret I; Dieu B; Lecam-Duchez V; Borg JY; Muller JM; Benhamou Y; Marie I
Thromb Haemost; 2008 Oct; 100(4):685-92. PubMed ID: 18841293
[TBL] [Abstract][Full Text] [Related]
28. [Time in therapeutic range (TTR) and follow-up of patients on vitamin K antagonist: A cohort analysis].
Valdelièvre E; Quéré I; Caré B; Laroche JP; Schved JF
J Med Vasc; 2018 May; 43(3):155-162. PubMed ID: 29754725
[TBL] [Abstract][Full Text] [Related]
29. Vitamin K antagonist anticoagulant usage is associated with increased incidence and progression of osteoarthritis.
Boer CG; Szilagyi I; Nguyen NL; Neogi T; Meulenbelt I; Ikram MA; Uitterlinden AG; Bierma-Zeinstra S; Stricker BH; van Meurs JB
Ann Rheum Dis; 2021 May; 80(5):598-604. PubMed ID: 34412027
[TBL] [Abstract][Full Text] [Related]
30. [Massive right auricular and ventricular thrombosis after Kaskadil administration in a patient with an overdose of antivitamin K].
Bonnet A; Rimmelé T; Crozon J; Pruvot S
Ann Fr Anesth Reanim; 2008 Apr; 27(4):348-9. PubMed ID: 18403177
[No Abstract] [Full Text] [Related]
31. Incidence and impact of atrial arrhythmias on thrombotic events in MPNs.
Mahé K; Delluc A; Chauveau A; Castellant P; Mottier D; Dalbies F; Berthou C; Guillerm G; Lippert E; Ianotto JC
Ann Hematol; 2018 Jan; 97(1):101-107. PubMed ID: 29164292
[TBL] [Abstract][Full Text] [Related]
32. Optimizing quality care for the oral vitamin K antagonists (VKAs).
Pengo V; Denas G
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):332-338. PubMed ID: 30504329
[TBL] [Abstract][Full Text] [Related]
33. [Stroke prevention in patients with atrial fibrillation].
Sirimarco G; Hirt L; Sztajzel R; Perren F
Rev Med Suisse; 2017 Apr; 13(560):911-915. PubMed ID: 28727359
[TBL] [Abstract][Full Text] [Related]
34. Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry.
Michalski F; Tittl L; Werth S; Hänsel U; Pannach S; Sahin K; Weiss N; Beyer-Westendorf J
Thromb Haemost; 2015 Nov; 114(5):1076-84. PubMed ID: 25994496
[TBL] [Abstract][Full Text] [Related]
35. [Accidents to AVK: a retrospective study of 30 cases].
Serghini I; Aissaoui Y; Quamouss Y; Sedikki R; Taj N; Salim Alaoui J; Zoubir M; Boughanem M
Pan Afr Med J; 2012; 11():24. PubMed ID: 22514758
[TBL] [Abstract][Full Text] [Related]
36. [INR and vitamin K antagonists management by the primary care physicians in Normandy].
Druilhe L; Humbert X
Ann Biol Clin (Paris); 2020 Apr; 78(2):157-173. PubMed ID: 32319944
[TBL] [Abstract][Full Text] [Related]
37. [Anticoagulants. Antivitamins K: principles and rules of use, posology].
Mismetti P; Decousus H
Rev Prat; 1995 Apr; 45(8):1014-7. PubMed ID: 7761767
[No Abstract] [Full Text] [Related]
38. [Anticoagulants after first pulmonary embolism: delaying relapse while balancing risk and benefit. ].
Fumeaux T
Rev Med Suisse; 2015 Sep; 11(486):1725. PubMed ID: 26591089
[No Abstract] [Full Text] [Related]
39. [Vitamin K antagonist, direct oral anticoagulants: Where is the truth?].
Laroche JP; Schved JF
J Mal Vasc; 2016 Dec; 41(6):383-388. PubMed ID: 27817997
[TBL] [Abstract][Full Text] [Related]
40. Long-term vitamin K antagonists treatment patterns of Non-Valvular Atrial Fibrillation (NVAF): a population-based cohort study.
Renoux C; Coulombe J; Suissa S
BMC Cardiovasc Disord; 2016 May; 16():84. PubMed ID: 27160254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
